Cannabis Infused Drinks Market

A convenience-store buyer weighing a four-pack of hemp-THC seltzer at USD 5.35 a can now has to price in a federal cut-off: under the FY2026 agriculture appropriations act signed on 12 November 2025, finished hemp products holding more than 0.4 milligrams of THC per container stop counting as hemp on 12 November 2026, according to the Congressional Research Service. The Cannabis Infused Drinks Market covers ready-to-drink beverages carrying tetrahydrocannabinol (THC), cannabidiol (CBD) or minor cannabinoids, sold through licensed cannabis stores, hemp retail and online. Douglas Insights puts 2025 at 328.6 million cans and bottles at an average USD 5.35, or USD 1.76 billion, rising to USD 3.43 billion by 2035 at a 6.90% revenue CAGR. Our research methodology and the wider beverages coverage explain how the unit build reconciles.

Why are adults swapping beer for 5 mg THC seltzers, and how much demand does that add?

Alcohol substitution, state-licensed dispensary drinks and new formats lift cannabis infused drinks volume by 4.6% a year to 2035. Douglas Insights expects 515.2 million units in 2035, against 328.6 million in 2025, with substitution supplying 2.1 points, dispensary drinks 1.5 points and format innovation 1.0 point.

Substitution is the largest lever, worth 2.1 points. In Canada, 21% of past-year cannabis consumers reported drinking cannabis beverages, per the Canadian Cannabis Survey 2024, which also found 26% of people aged 16 and older used cannabis in the past 12 months. Those consumers spend about CAD 63 a month on cannabis. A 355 ml can dosed at 2.5 mg to 10 mg THC fits the session-beer occasion, and brewers have noticed. Tilray, which calls itself the fifth-largest craft brewer in the US, announced hemp-derived delta-9 THC drinks on 24 September 2024 at 5 mg per can under its 420 Fizz, Herb and Bloom, Fizzy Jane’s and Happy Flower brands, according to its investor release.

Dispensary drinks add 1.5 points. US adult-use stores carry beverages under state-set potency limits, and that channel survives the federal hemp redefinition intact. Douglas Insights estimates the licensed-dispensary drink channel at USD 172.4 million in 2025, under one tenth of the cannabis infused drinks total, but the share rises as hemp-channel volume migrates after November 2026.

Format innovation adds the final 1.0 point. Teas, lemonades, dealcoholised beer bases and 60 ml shots widen the cannabis infused drinks shelf beyond sparkling water. Canopy Growth ships Deep Space and Tweed iced teas and sparkling lemonades in Canada, while Organigram said on 8 July 2025 that its Collective Project beverage arm would ship hemp-derived THC drinks to 25 US states, per its company release. More formats mean more occasions per buyer. Douglas Insights counts 5 product formats in its segment model, and the 3 non-seltzer formats together grow at about 8.4% a year, against 6.5% for seltzers. A drinker who buys a tea for a barbecue and a shot for a dinner party doubles the cannabis infused drinks occasions that one sparkling can served. Brewers already run the canning and cold-chain lines these formats need.

Price adds a further 2.2 points a year, taking the average can from USD 5.35 to USD 6.65. Premium nano-emulsion drinks and dispensary pricing pull the mix upward.

Which headwinds hold back cannabis drink volume after the hemp redefinition?

Three headwinds take about 3.2 points off cannabis infused drinks volume growth, which would otherwise run near 7.8% a year. The 0.4 mg per-container federal hemp limit removes 1.9 points, Canada’s 10 mg container cap 0.8 points and alcohol-aisle shelf access 0.5 points.

The federal hemp redefinition is the heaviest drag, at 1.9 points. From 12 November 2026, a 5 mg hemp seltzer is no longer hemp under federal law, the Congressional Research Service notes, which pushes roughly USD 1.07 billion of 2025 US hemp-channel cannabis drink sales toward state licensing or out of the market. Some volume moves into dispensaries; some does not.

Canada’s potency cap removes 0.8 points. Health Canada limits each container of edible cannabis, the class that includes cannabis drinks, to 10 mg of THC, so Canadian cannabis infused drinks cannot follow the higher-dose US dispensary products. Beverages held 1.6% of Canadian cannabis sales in 2023/2024, per Statistics Canada, a share that has stayed small.

Shelf access takes 0.5 points. Cannabis infused drinks cannot sit beside beer in most liquor stores, so trial depends on dedicated stores. Shelf rules differ in every state.

Which drink format makes the money in cannabis infused drinks: seltzers, teas or dealcoholised beers?

THC seltzers and sodas lead cannabis infused drinks with 46.3% of 2025 value, or USD 814.0 million, because the 355 ml sparkling can is the format hemp brands and brewers launched first. Cannabis-infused dealcoholised beers and wines grow fastest, at 9.1% a year.

THC seltzers and sodas hold USD 814.0 million because a low-calorie sparkling base hides cannabinoid bitterness well. CBD and minor-cannabinoid drinks carry USD 341.1 million, 19.4% of value, and grow slowest at 4.3% because non-intoxicating drinks lack a clear repeat reason. THC teas and lemonades take USD 277.8 million; sweeter bases let brands dose 5 mg to 10 mg without off-notes, supporting 8.6% growth. Cannabis-infused dealcoholised beers and wines account for USD 179.3 million and expand 9.1% a year, the fastest, as brewers reuse dealcoholisation lines already built for the Non-Alcoholic Beer Market and the Non-Alcoholic Wine Market. Drink shots and mixers hold USD 145.9 million, 8.3%, rising at 7.2% as 60 ml formats suit bar-style mixing.

Where are cannabis drinks sold most: North America, Europe or Asia Pacific?

North America holds 83.6% of cannabis infused drinks value, USD 1.47 billion in 2025, because the US hemp channel and Canadian licensed stores are the only large legal drink markets. Asia Pacific grows fastest at 9.4% a year from a USD 93.2 million base.

North America reaches USD 2.78 billion by 2035 at 6.57% a year, slowed by the 2026 hemp reset. Canada is a small part of that: Douglas Insights calculates Canadian cannabis drinks at about USD 60.7 million, from CAD 5.2 billion of national cannabis sales and a 1.6% beverage share reported by Statistics Canada. Europe holds USD 138.9 million in 2025, mostly CBD drinks under novel-food scrutiny, and grows 7.9% to USD 297.1 million. Asia Pacific rises from USD 93.2 million to USD 228.9 million at 9.4%, the fastest pace, as hemp-seed and CBD drink approvals widen in a handful of markets. Latin America, the wildcard, holds USD 36.9 million and grows 8.7% to USD 85.0 million; any adult-use reform there would reprice the cannabis drink forecast. The Middle East and Africa hold USD 19.3 million, rising 7.15% to USD 38.5 million.

Which companies sell the most cannabis infused drinks, and what are their positions built on?

Douglas Insights estimates the top three cannabis infused drinks sellers held about 21.4% of 2025 value, an estimate built on brand counts and disclosed channel reach rather than reported beverage revenue. Brewer-backed and Canadian licensed-producer brands lead a fragmented field.

Tilray holds the strongest cannabis drink position in Canada: its November 2023 release called XMG the number one brand in cannabis-infused beverages, and on 24 September 2024 it extended into US hemp drinks through its brewing distribution, according to its investor release. Organigram claims the number one share position in Canadian cannabis overall and, on 8 July 2025, said US hemp-derived THC drinks had passed USD 1 billion in retail sales, per its company release. Canopy Growth builds on Tweed and Deep Space in Canadian stores. Boston Beer Company brings TeaPot iced teas at 5 mg per 12 oz can, produced in Windsor, Ontario. Molson Coors built its Canadian cannabis drink know-how through Truss Beverage, the 2018 joint venture with HEXO, which supplied the cannabis inputs. Private US hemp brands sold through liquor stores face the most exposure to the 12 November 2026 cut-off.

What do buyers pay per can of cannabis infused drink, by channel?

USD 5.35 is the 2025 average realised retail price per cannabis infused drink, across seltzers, teas, shots and CBD drinks. Bands run from about USD 3.50 for a 2 mg hemp seltzer in a four-pack to USD 9.00 or more for single dispensary cans.

Hemp-channel cannabis infused drinks in liquor and convenience stores usually sell in four-packs at USD 16 to USD 24, or USD 4.00 to USD 6.00 per can, on Douglas Insights price assumptions. Dispensary drinks carry excise and state taxes, so we model a 10 mg can at USD 6.50 to USD 9.50. Canadian cannabis drinks, capped at 10 mg THC, are modelled at CAD 5 to CAD 7 per 355 ml can. CBD drinks sit lowest, at USD 3.00 to USD 4.50. Douglas Insights forecasts the blended price at USD 5.47 in 2026 and USD 6.65 in 2035, a 2.2% annual rise, as dispensary mix grows.

How does the 0.4 mg per-container hemp rule and Canada’s 10 mg cap regulate cannabis drinks?

Two potency rules set the cannabis infused drinks shelf: a 0.4 mg THC per-container limit for US hemp products from 12 November 2026, and a 10 mg THC per-container cap on Canadian edible cannabis. State laws fill the gaps between them.

The US rule came through P.L. 119-37, Division B, enacted on 12 November 2025; it also kept the 0.3% dry-weight THC test and gave the Food and Drug Administration (FDA) 90 days to publish cannabinoid lists, per the Congressional Research Service. Minnesota already permits lower-potency hemp beverages at up to 10 mg THC per container, two servings of 5 mg each, according to the Office of Cannabis Management. Canada’s 10 mg cap applies per immediate container of edible cannabis under Health Canada packaging and labelling rules. For a cannabis drink brand, the practical question is which state licence replaces the federal hemp route.

What could change the 2035 cannabis infused drinks forecast?

Douglas Insights projects cannabis infused drinks at USD 3.43 billion by 2035 in the base case, with a slower case of USD 2.54 billion and a faster case of USD 4.64 billion. The spread depends mostly on how much US hemp-channel volume finds a state licence after 12 November 2026.

The base case runs 4.6% volume and 2.2% price. The slower case, 2.1% volume and 1.6% price, assumes most states do not license hemp drinks after the federal cut-off. The faster case, 7.4% volume and 2.6% price, assumes broad state beverage licensing and Canadian cap relief. One extra point of yearly volume growth adds about USD 342.0 million to the 2035 cannabis drink figure. Published forecasts sit between 5.24% and 17.77% a year; our 6.90% sits near the low end because we model the 12 November 2025 law, which most of those forecasts predate.

Douglas Exclusive: the cannabis drink potency-and-channel matrix

The potency-and-channel matrix is a Douglas Insights model built from 11 inputs. It uses 6 figures and rules sourced in this study and 5 of our own assumptions, including a CAD to USD rate of 0.73 and the USD 5.35 average can price. It crosses 4 regulatory regimes with 3 channels to show where cannabis infused drinks value is exposed.

The matrix finds that about 61% of 2025 cannabis infused drinks value sits in the single regime whose rules change in November 2026. Douglas Insights reckons the US non-hemp residual, mainly CBD drinks and imports, at USD 166.6 million, which closes the matrix to USD 1.76 billion. Our finding: regulatory exposure, not consumer demand, is the largest single source of forecast risk.

Who drinks cannabis infused drinks, and how often?

About 21% of Canadian past-year cannabis consumers drink cannabis beverages, per the 2024 Health Canada survey, making drinks a minority but repeat format. Douglas Insights models 328.6 million cans in 2025, a figure built from value rather than from a consumer count.

Cannabis infused drinks skew toward adults who already drink alcohol and want a lower-calorie, hangover-free option. The Canadian Cannabis Survey 2024 found 72% of past-year consumers usually buy from a legal source, a high legal share for a regulated product. Low doses suit social settings. Heavy users prefer flower.

Which sales channel carries cannabis drinks: dispensary, liquor store or online?

Liquor and convenience stores carried about 61% of 2025 cannabis infused drinks value through the US hemp route, and that share falls after November 2026. Licensed dispensaries hold under 10%, and online direct-to-consumer shipping fills part of the rest.

Online sales grew when Organigram’s Collective Project opened shipping to 25 states in July 2025. Dispensary cannabis drinks gain share as hemp products exit. Canadian cannabis drinks move through provincial wholesalers such as the Ontario Cannabis Store. Douglas Insights expects licensed dispensaries to approach one third of cannabis drink value by 2035.

How the model builds 328.6 million cannabis drink units into USD 1.76 billion?

Douglas Insights multiplies 328.6 million cannabis infused drinks units by a USD 5.35 average price to reach USD 1.76 billion. The model covers 5 regions, 5 product segments, 4 regulatory regimes and 11 inputs.

Canada is built from CAD 5.2 billion of 2023/2024 cannabis sales times the 1.6% beverage share, or CAD 83.2 million, converted at 0.73 to USD 60.7 million. US hemp drinks are anchored on Organigram’s statement that sales passed USD 1 billion; we use USD 1.07 billion. Cross-check one: the bottom-up regional sum matches the global total within USD 0.1 million. Cross-check two: our 2025 figure sits 3.4% above the USD 1.7 billion CBD-drink estimate one rival publishes, a reasonable gap given our THC coverage. The 2035 figure of USD 3.43 billion compounds 4.6% volume and 2.2% price for 10 years.

Sources

1. Congressional Research Service Change to Federal Definition of Hemp (IN12620) (2025)
2. Statistics Canada Alcohol and cannabis sales in Canada, April 2023 to March 2024 (2025)
3. Health Canada Canadian Cannabis Survey 2024: Summary (2024)
4. Tilray Brands Hemp-derived delta-9 THC drinks launch (2024)
5. Organigram Global Collective Project direct-to-consumer launch (2025)
6. Minnesota Office of Cannabis Management Cannabinoid products overview (2025)